⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL155154 | 1.00 | — | — | |
| SCHEMBL12035161 | 1.00 | — | — | |
| SCHEMBL9695112 | 1.00 | SMN1; SMN2 (0.42) | — | |
| SCHEMBL229160 | 1.00 | — | — | |
| SCHEMBL229159 | 1.00 | — | — | |
| SCHEMBL13748630 | 1.00 | — | — | |
| SCHEMBL155155 | 1.00 | — | — | |
| SCHEMBL9695108 | 1.00 | SMN1; SMN2 (0.42) | — | |
| SCHEMBL158741 | 1.00 | — | — | |
| SCHEMBL1912136 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260001889-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS INC (US) | 2026-01-01 | — | — | US | disclosed |
| EP-4522622-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| WO-2023220439-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023220439-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| US-20230159519-A1 | NOVEL COMPOUNDS AND THEIR USE | DEBIOPHARM INTERNATIONAL S.A. (CH) | 2023-05-25 | — | — | US | disclosed |
| CN-108368032-B | Phenolic acid derivative compound and application thereof | 大峰LS株式会社 | 2021-06-08 | — | — | CN | disclosed |
| US-10696623-B2 | Phenolic acid derivative compound and use thereof | DAEBONG LS, LTD (KR) | 2020-06-30 | — | — | US | disclosed |
| US-20180362448-A1 | NOVEL PHENOLIC ACID DERIVATIVE COMPOUND AND USE THEREOF | DAEBONG LS, LTD (KR) | 2018-12-20 | — | — | US | disclosed |
| CN-108368032-A | Novel phenolic acid class derivative compound and application thereof | 大峰LS株式会社 | 2018-08-03 | — | — | CN | disclosed |
| US-9839641-B2 | Compounds and methods for treating bacterial infections | ENTASIS THERAPEUTICS LIMITED (GB) | 2017-12-12 | — | — | US | disclosed |
| US-20090163496-A1 | ANTIBACTERIAL AGENTS | UNIVERSITY OF WASHINGTON (US) | 2009-06-25 | — | — | US | disclosed |
| WO-2008154642-A2 | ANTIBACTERIAL AGENTS | ACHAOGEN, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| US-7358359-B2 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2008-04-15 | — | — | US | disclosed |
| WO-2008028937-A1 | N-BIARYL (HETERO) ARYLSULPHONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY LYMPHOCYTES INTERACTIONS | NOVARTIS AG (CH) | 2008-03-13 | — | — | WO | disclosed |
| US-20070244197-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2007-10-18 | — | — | US | disclosed |
| US-20070244197-A1 | Antibacterial agents | UNIVERSITY OF WASHINGTON (US) | 2007-10-18 | — | — | US | disclosed |
| US-7183417-B2 | Simple stereocontrolled synthesis of salinosporamide A | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-02-27 | — | — | US | disclosed |
| EP-1745048-A2 | SIMPLE STEREOCONTROLLED SYNTHESIS OF SALINOSPORAMIDE A | The President and Fellows of Harvard College (US) | 2007-01-24 | — | — | EP | disclosed |
| WO-2005113558-A2 | SIMPLE STEREOCONTROLLED SYNTHESIS OF SALINOSPORAMIDE A | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20050228186-A1 | Simple stereocontrolled synthesis of salinosporamide A | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2005-10-13 | — | — | US | disclosed |